About Us

A Tianjin, China manufacturer focused on in-vitro diagnostics and cell biotherapy

MD Pacific (Tianjin) Biotechnology Co., Ltd. was founded in 2003 and is registered at the Huayuan Hi-tech Green Industrial Base in Tianjin. With over two decades in the in-vitro diagnostics (IVD) field, we have long served hospitals at all levels across China, meeting clinical testing needs in coagulation, specific protein, and related areas, while steadily expanding into overseas markets — our products are now sold to more than 20 countries and regions. The company focuses on the independent R&D and manufacturing of IVD instruments and matching reagents, with its own R&D center, an experienced R&D team, and multiple proprietary IP rights.

The company holds National High-tech Enterprise and Tianjin Specialized, Refined, Distinctive and Innovative SME status, and operates a roughly 1,000 m² reagent workshop built to GMP cleanroom standards. It is certified to the ISO 13485:2016 and EN ISO 13485:2016 medical device quality management system standards, holds CE certification, and has TÜV SÜD recognition (audited by SGS, certificates verifiable).